According to a press release from Inovio Pharmaceuticals, the American biotech company’s experimental recurrent respiratory papillomatosis (RRP) drug INO-3106 showed promising results at the end
According to a story from finanzen.at, the biotechnology company Orbsen Therapeutics recently announced that its immunotherapy product ORBCEL-C is to be tested in a multi-site
People living with rare diseases such as amyotrophic lateral sclerosis (ALS) or muscular dystrophy as well as those who have suffered from a stroke or
According to a story from Xconomy, a recent report from the Institute for Clinical and Economic Review (ICER), based on Boston, is calling for reductions
According to a publication from Multiple Sclerosis News Today, recent studies of mesenchymal stem cells (MSCs – adult stem cells) suggest that autologous transplant of
According to a recent article in Check Orphan, genetic and biochemical testing are combined in a new method of metabolic testing called the CentoMetabolic
© Copyright Patient Worthy
